Sysmex : Announcement Regarding Impairment Losses (Consolidated Financial Results), as well as Revision of Full-Year Financial Forecast for the Fiscal Year Ending March 31, 2026

April 28, 2026

Sysmex Corporation (HQ: Kobe, Japan; President: Iwane Matsui) hereby announces that, in the fourth quarter of the fiscal year ending March 31, 2026, it will record an impairment loss in its consolidated financial statements, as set forth below.

Accordingly, the Company also announces a revision to the full-year financial forecast for the fiscal year ending March 31, 2026, which was previously announced on February 12, 2026.

1. Impairment Loss (Consolidated Financial Results)

   The Company announces that it will record an impairment loss of 11,557 million yen as other operating expenses in the fourth quarter of the fiscal year ending March 31, 2026.

   The principal components of this impairment loss relate to goodwill recognized at the time of acquisition of the Company's consolidated subsidiaries, namely Sysmex Partec GmbH, Oxford Gene Technology IP Limited, and Sysmex Astrego AB. Based on the results of impairment testing conducted in light of revised assumptions regarding future cash flow projections, changes in the business environment and business strategy, the Company determined that the recoverable amounts of these assets had fallen below their carrying amounts.

2. Revised Consolidated Financial Forecast for the Fiscal Year Ending March 31, 2026 (April 1, 2025 to March 31, 2026)

   Due to the recording of the impairment loss described above, operating profit, profit before tax, and

   profit attributable to owners of the parent are expected to fall below the previously announced forecast. Accordingly, the Company has revised its forecast.

   (Millions of yen, unless otherwise stated)

   	Net sales	Operating profit	Profit before tax	Profit attributable to owners of the parent	Basic earnings per share (Yen)
   Previous forecast (A)	500,000	62,000	59,000	41,000	65.77
   Revised forecast (B)	500,000	51,000	49,000	35,000	57.05
   Difference (B-A)	-	(11,000)	(10,000)	(6,000)	-
   Rate of change (%)	-	(17.7)	(16.9)	(14.6)	-
   (Reference) Results for fiscal year ended March 31, 2025	508,643	87,583	79,221	53,669	86.07

   Note: The forecasts above were made based on information available on the day of this release.

   Actual results may therefore differ materially from those described above due to various unforeseen factors and possible events in the future.

3. Dividend Forecast

Regarding the dividend forecast, there is no change from the forecast announced on May 14, 2025.